Home > Boards > US Listed > Biotechs > Staar Surgical Co. (STAA)

NEWS! NEWS!!!!!!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
scott64 Member Profile
 
Followed By 72
Posts 6,141
Boards Moderated 1
Alias Born 03/09/08
160x600 placeholder
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 1/20/2021 10:05:15 AM
Report of Proposed Sale of Securities (144) Edgar (US Regulatory) - 1/12/2021 5:30:00 PM
STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2020 Results Business Wire - 1/10/2021 6:00:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/4/2020 4:56:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/25/2020 4:09:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/23/2020 4:52:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/17/2020 4:53:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/12/2020 4:53:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/12/2020 4:51:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/12/2020 4:50:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 4:53:28 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/4/2020 4:12:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/4/2020 4:07:43 PM
STAAR Surgical Begins Commercialization of EVO Viva™ Presbyopia Correcting Lens Business Wire - 11/4/2020 4:03:00 PM
STAAR Surgical Reports Third Quarter 2020 Results Business Wire - 11/4/2020 4:01:00 PM
STAAR Surgical to Report Third Quarter Results on November 4, 2020 Business Wire - 10/21/2020 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/16/2020 6:02:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/14/2020 9:01:07 AM
STAAR Surgical Announces Completion of Patient Enrollment in EVO Implantable Lens US Clinical Trial Business Wire - 9/14/2020 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2020 4:07:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/2/2020 8:31:51 AM
STAAR Surgical to Participate in Upcoming Investor Conferences Business Wire - 9/2/2020 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/12/2020 6:30:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/12/2020 6:29:21 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/12/2020 6:27:50 PM
scott64   Thursday, 06/11/09 08:16:05 AM
Re: None
Post # of 28 
NEWS! NEWS!!!!!!
Free Stock Symbol Lookup - Scottrade: Leading stock research

Press Release Source: STAAR Surgical Company
STAAR Surgical Receives FDA Clearance for the Epiphany(TM) Injector System

* On Thursday June 11, 2009, 8:00 am EDT

*
Buzz up!
* Print

Related:

* STAAR Surgical Company

MONROVIA, Calif., June 11 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA - News), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that the FDA has granted 510(k) clearance for its Epiphany Injector System for use with the Affinity(TM) Collamer® Three-Piece NTIOL and the Elastimide(TM) Silicone NTIOL. Introduction of the Epiphany will usher in a new era of insertion devices for the company and pave the way for the future introduction of a preloaded injector for the U.S. market.
Related Quotes
Symbol Price Change
STAA 1.49 0.00
Chart for STAAR Surgical Company
{"s" : "staa","k" : "c10,l10,p20,t10","o" : "","j" : ""}

STAAR named this product "Epiphany" based on the genesis of the product: the realization that the revolutionary proprietary technology used in our preloaded products outside of the U.S. could be modified and incorporated into a stand-alone injector for IOLs in other markets. Epiphany has been designed to combine both ease of use with controlled delivery. The Epiphany injector system is intended for single use and offers the flexibility of either twist or push insertion techniques - a unique feature of STAAR's IOL delivery systems.

"The Epiphany Injector System is an important extension of STAAR Japan's expertise in the area of preloaded delivery systems for foldable IOLs which have been very successful in the Japanese market," said Barry G. Caldwell, President and CEO of STAAR Surgical. "This product will enhance the ability of surgeons to accurately deliver the Collamer Three-Piece NTIOL into the eye and it serves as the forerunner in our regulatory pathway for potential approval of the preloaded delivery system in the U.S."

As the Epiphany provides for effortless yet controlled insertion through a 2.8mm incision and, being a single use product, ensures a sterile pathway into the eye. The Epiphany's planar delivery of the lens into the eye offers controlled release of the lens haptics which is another clear advantage that will help differentiate this the new system in the market place.

First shipments of the product should begin in July with full release to the market in the August timeframe.

About STAAR Surgical

STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 50 countries. Collamer® is the brand name for STAAR's proprietary collagen copolymer lens material. More information is available at www.staar.com.

Safe Harbor

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences